Reduction of cell cycle progression in human erythroid progenitor cells treated with tumour necrosis factor alpha occurs with reduced CDK6 and is partially reversed by CDK6 transduction.

Source:http://linkedlifedata.com/resource/pubmed/id/12786804

Download in:

View as

General Info

PMID
12786804